Rapid lateral flow immunoassay device for simultaneous detection of COVID-19, Influenza A, and Influenza B antigens from saliva or respiratory samples. Enables point-of-care multiplex viral screening with results in 15-20 minutes, supporting clinical diagnosis and infection control in healthcare and...
Manufactured by
Taizhou, Jiangsu, China
Kaimi Biotech, located in Jiangsu, China, develops and manufactures novel medical diagnostic products with our proprietary technologies. We firmly believe that excellent products rely on innovative materials and robust production processes. we are fully committed to investing on development of novel materials and manufacturing processes to deliver new products with great performance and help our customers solve challenging requirements of medical diagnostics.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ProGnosis Biotech S.A.
Greece · 3 relevant products
Hangzhou Genesis Biodetection & Biocontrol Co., Ltd.
China · 4 relevant products
AssureTech.(Hangzhou) Co.,Ltd.
China · 3 relevant products
Shenzhen Microprofit Biotech Co., Ltd
China · 2 relevant products
Hangzhou Realy Tech Co., Ltd
China · 2 relevant products
Zhejiang Orient Gene Biotech Co.,Ltd.
China · 1 relevant product
Biopanda Reagents
United Kingdom · 3 relevant products
SureScreen Diagnostics Limited
United Kingdom · 1 relevant product
Zhejiang QL Biotech Co., Ltd.
China · 3 relevant products
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 6 relevant products
64 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 110 closest product alternatives
ProGnosis Biotech S.A. · Greece
Rapid antigen test for simultaneous detection of influenza A & B and COVID-19 using advanced antigen-antibody technology. Delivers fast, reliable results for respiratory infection screening in clinical settings. ELISA and lateral flow formats available for point-of-care and laboratory use.
Hangzhou Genesis Biodetection & Biocontrol Co., Ltd. · China
A rapid diagnostic test device for the simultaneous detection of influenza and SARS-CoV-2 antigens.
Hangzhou Genesis Biodetection & Biocontrol Co., Ltd. · China
A rapid test for the detection of influenza, influenza B and SARS-CoV-2 antigens in nasal specimens. Intended for self-test use.
AssureTech.(Hangzhou) Co.,Ltd. · China
Rapid antigen detection device for COVID-19 diagnosis at point-of-care settings. Delivers qualitative results to identify active SARS-CoV-2 infection from respiratory samples. Designed for clinical and screening applications requiring quick turnaround times.
Shenzhen Microprofit Biotech Co., Ltd · China
CE-marked rapid self-test kit for simultaneous detection of SARS-CoV-2, Influenza A+B, and RSV with 92.9%+ sensitivity. Delivers point-of-care respiratory diagnostics using fluorescence immunoassay technology for clinical and home-based testing environments.
Hangzhou Realy Tech Co., Ltd · China
A rapid antigen test device for the detection of SARS-Cov-2 using saliva samples. This non-invasive test is designed for COVID-19 screening and diagnosis.
Zhejiang Orient Gene Biotech Co.,Ltd. · China
Point-of-care diagnostic test for simultaneous detection of influenza A and B viruses. Results available within 10-15 minutes, enabling rapid clinical decision-making.
Hangzhou Genesis Biodetection & Biocontrol Co., Ltd. · China
A multiplex rapid test for simultaneous detection of COVID-19, influenza, RSV, and adenovirus antigens. Enables comprehensive respiratory pathogen screening in clinical settings.
Biopanda Reagents · United Kingdom
Lateral flow immunoassay for rapid detection of SARS-CoV-2 antigen in respiratory specimens. Provides quick results for point-of-care COVID-19 diagnosis in clinical and laboratory settings.
SureScreen Diagnostics Limited · United Kingdom
A rapid diagnostic test that delivers simultaneous results for both COVID-19 and influenza viruses, helping clinicians make informed decisions and patients receive appropriate care quickly.
Zhejiang QL Biotech Co., Ltd. · China
Jiangsu Medomics Medical Technology Co.,Ltd. · China
Rapid lateral flow immunoassay (LFIA) for simultaneous qualitative detection of SARS-CoV-2, influenza A and B, adenovirus, respiratory syncytial virus, and Streptococcus A antigens. Designed for point-of-care respiratory pathogen screening in clinical and self-testing settings.
98 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products